Table 3.
Entire Cohort [n (%)] |
Primary Diagnosis Respiratory Failure [n (%)] |
Primary Diagnosis Asthma Exacerbation [n (%)] |
|||||||
---|---|---|---|---|---|---|---|---|---|
Total (N = 53,654) | Noninvasive Ventilation (n = 13,540) | No Noninvasive Ventilation (n = 40,114) | Total (n = 17,387) | Noninvasive Ventilation (n = 6,457) | No Noninvasive Ventilation (n = 10,930) | Total (n = 37,361) | Noninvasive Ventilation (n = 7,510) | No Noninvasive Ventilation (n = 29,851) | |
Invasive mechanical ventilation | 14,498 (27.0) | 3,013 (22.3) | 11,485 (28.6) | 8,829 (50.8) | 1,942 (30.1) | 6,887 (63.0) | 6,156 (16.6) | 1,175 (15.6) | 4,981 (16.7) |
In-hospital mortality | 1,291 (2.4) | 223 (1.7) | 1,068 (2.7) | 860 (5.0) | 151 (2.3) | 709 (6.5) | 443 (1.2) | 75 (1.0) | 368 (1.2) |
Propensity-matched cohort | n = 25,450 | n = 12,725 | n = 12,725 | n = 11,350 | n = 5,675 | n = 5,675 | n = 14,846 | n = 7,423 | n = 7,423 |
Invasive mechanical ventilation | 8,197 (31.7) | 2,897 (22.4) | 5,300 (40.1) | 5,095 (44.9) | 1,808 (35.5) | 3,287 (64.5) | 3,111 (21.0) | 1,161 (15.6) | 1,950 (26.8) |
In-hospital mortality | 605 (2.3) | 216 (1.7) | 389 (3.0) | 390 (3.4) | 137 (2.4) | 253 (4.5) | 197 (1.3) | 74 (1.0) | 123 (1.7) |